An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of topical C-KAD
Ophthalmic Solution in reducing intraocular pressure in patients with ocular hypertension.